Atrioventricular Block and Cluster Headache (SEVA)
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Verapamil is a calcium channel blocker widely used to treat cardiovascular diseases however
it is also the first line treatment in the prevention of cluster headaches. In France, its
prescription in that indication is based on compliance with the Temporary Recommendation for
Use (RTU) that insists on the possible the cardiac side effects that can occur as the doses
required for cluster headache are significantly higher than the doses used in cardiology.